The New European Pharmacovigilance Legislation July 2012

Jul 18, 2012
Order the DVD of this seminar

Course Description

In July 2012, new pharmacovigilance legislation will come into effect across the European Union (EU) as a result of changes set out in Regulation (EU)No1235/2010: and Directive 2010/84/EU. The legislation will be underpinned by a European Commission (EC) Implementing Measures Regulation and a series of modules on Good Pharmacovigilance Practice. Are you confident your pharmacovigilance operations will meet the EU’s latest expectations for compliance? Do you understand the processes needed to perform adequate risk assessment? Not knowing which systems and processes you must have in place for the new European pharmacovigilance requirements could have significant consequences for your product. You must be sure you have the understanding you need to be able to work to EU standards and have implemented regulatory requirements for signaling and risk management. This web seminar is designed to give pharmaceutical and biologic companies operating in the EU an introduction to the new European pharmacovigilance requirements. We will address: audits and inspections; ADR reporting and signal management; Periodic Safety Update Reports; risk minimization; Risk Management Plans; and post authorization studies.


Learning Objectives

  • Navigate the new EU regulatory requirements for drug safety
  • Process Adverse Events to meet EU requirements
  • Prepare for an European pharmacovigilance inspection

Who Should Attend

  • Drug Safety and Pharmacovigilance Personnel
  • Regulatory Affairs Professionals
  • Clinical Development Staff
  • Executives (including C-Level) with any legal responsibility for drug safety


Steve Jolley

Click here for complete trainer biographies 

Hold this course at your company! For more information, contact Naila Ganatra at (215) 413-2471.